Photo:
m4rd.org
Apr 13, 2026, 13:02
CAN-ACT Reaches 200 Patients in Six Months – Loeys-Dietz Syndrome Foundation Canada
Loeys-Dietz Syndrome Foundation Canada shared a post on LinkedIn:
“Milestone achieved: 200 patients enrolled in just six months!!
This important achievement reflects the growing momentum of the Canadian Aortopathy and Connective Tissue Disorders Registry (CAN-ACT), a national initiative advancing research on heritable syndromic aortopathies across Canada.
By integrating clinical, genetic, and quality-of-life data, CAN-ACT is helping drive earlier diagnosis, improved care, and stronger advocacy for these rare conditions.”
Stay updated with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention